Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹59.72
Market cap: ₹128.8 Cr
Revenue (annual): ₹23.73 Cr
Net profit (annual): ₹-16.93 Cr
P/E (TTM): -9.1×Sector 47.3×
Promoter holding: 72.74%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Price Movement Clarification 2 Board Meeting Date 2 Other Announcement 1 Merger & Restructuring 1 Legal & Regulatory 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Aug 2026 13:43 IST BSE

Financial Results

Krebs Biochemicals & Industries Q1 FY27 Results: Net Loss of ₹2.5 Cr, Loss Narrows

Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹7 Cr (+27.3% YoY) and a net loss of ₹2.5 Cr for Q1 FY27.

Key figure: Net loss ₹2.5 Cr

Open full results → Read the filing ↗

21 May 2026 13:23 IST BSE

Financial Results

Krebs Biochemicals & Industries Q4 FY26 Results: Net Loss of ₹2.3 Cr, Loss Narrows

Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹6.8 Cr (+11.5% YoY) and a net loss of ₹2.3 Cr for Q4 FY26.

Key figure: Net loss ₹2.3 Cr

Open full results → Read the filing ↗

21 May 2026 13:22 IST BSE

Financial Results

Krebs Biochemicals & Industries Financial Results

Krebs Biochemicals reported audited financial results for the year ended March 31, 2026. The company posted a total income of ₹25.76 Crore for the fiscal year.

Read the filing ↗